Webinar via Teams Live Event
Kirby Institute Seminar Series presents
Professor Raina MacIntyre
Raina MacIntyre is an internationally recognised expert in immunisation, especially adult vaccination. She has over 200 peer reviewed publications in vaccinology, including influenza, pneumococcal, herpes zoster, measles, HPV, hepatitis A, pertussis and smallpox vaccines. She has conducted several clinical trials of vaccines, including in older adults and immunosuppressed patients. She won the Public Health Association of Australia Immunisation Achievement Award in 2014 and is on the Vaccine Council of 100 for the journal, Vaccine. She worked for 15 years at the National Centre for Immunisation Research and has led a NHMRC Centre for Research Excellence in Immunisation in high risk groups from 2011-2016.
Ms Mallory Trent
Mallory Trent is a PhD candidate with the Kirby's Biosecurity Program led by Professor Raina MacIntyre. Her PhD, entitled "Barriers and enablers of vaccination – informing whole of life vaccination policy" is focused on gaining a deeper understanding of vaccine hesitancy and assessing current vaccine policies in Australia.
Several vaccines for SARS-CoV-2 are expected to be available in Australia in 2021. Initial supply is likely to be limited, and will require a judicious vaccination strategy until supply is unrestricted. In this webinar the principles of vaccinology and vaccination programs will be discussed, as well as the impact of alternative vaccine strategies, such as post-exposure prophylaxis (PEP), risk and age-targeted vaccination and mass vaccination. Success for COVID-19 vaccination programs requires high levels of vaccine acceptance, but new research suggests there is widespread hesitancy to receive the vaccine.
Professor Raina MacIntyre will present results of a modelling study on competing vaccine program alternatives (mass vs targeted vaccination and post-exposure prophyalxis), speed of vaccination and herd immunity.
Ms Mallory Trent will present findings from a survey on COVID-19 vaccine attitudes and intentions in five cities with varying COVID-19 incidence in the US, UK, and Australia